BARD1 LIFE SCIENCES
BARD1 Life Sciences Ltd (ASX:BD1) is an Australian life sciences company focused on developing and commercialising non-invasive diagnostic tests for early detection of cancer. BARD1’s proprietary technology platform is based on novel tumour markers with potential diagnostic and therapeutic applications across multiple cancers. The pipeline includes two development-stage BARD1 autoantibody tests for early detection of lung and ovarian cancers, and a research-stage cancer vaccine under evaluation for treatment of cancer. Additional diagnostic projects are being evaluated for prostate, breast and other cancers. BARD1 is committed to transforming the early detection and prevention of cancer to help improve patients’ lives.
BARD1 LIFE SCIENCES
Industry:
Biotechnology Health Diagnostics Life Science
Founded:
1983-01-01
Address:
Nedlands, Western Australia, Australia
Country:
Australia
Website Url:
http://www.bard1.com
Total Employee:
11+
Status:
Active
Contact:
+61 8 9381 9550
Email Addresses:
[email protected]
Total Funding:
18.58 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS ReCAPTCHA V2 CPanel
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-12-29 | BARD1 | BARD1 acquired by BARD1 Life Sciences | N/A |
Investors List
Venture Kick
Venture Kick investment in Post-IPO Equity - BARD1 Life Sciences
Venture Kick
Venture Kick investment in Post-IPO Equity - BARD1 Life Sciences
Official Site Inspections
http://www.bard1.com
- Host name: 104.21.46.151
- IP address: 104.21.46.151
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
